{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T02:58:04Z","timestamp":1787626684814,"version":"build-2736575974"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T00:00:00Z","timestamp":1553817600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s10787-019-00582-9","type":"journal-article","created":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T10:03:15Z","timestamp":1553853795000},"page":"475-485","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["A double-blind randomized placebo controlled study assessing safety, tolerability and efficacy of palmitoylethanolamide for symptoms of knee osteoarthritis"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4743-2751","authenticated-orcid":false,"given":"Elizabeth","family":"Steels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchitha","family":"Venkatesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Steels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Vitetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7490-9298","authenticated-orcid":false,"given":"Luis","family":"Vitetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,29]]},"reference":[{"key":"582_CR1","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1016\/j.drudis.2014.06.007","volume":"19","author":"M Alhouayek","year":"2014","unstructured":"Alhouayek M, Muccioli GG (2014) Harnessing the anti-inflammatory potential of palmitoylethanolamide. Drug Discov Today. 19:1632\u20131639","journal-title":"Drug Discov Today."},{"key":"582_CR2","doi-asserted-by":"publisher","first-page":"85","DOI":"10.12816\/0006075","volume":"8","author":"A Alshami","year":"2014","unstructured":"Alshami A (2014) Knee osteoarthritis related pain: a narrative review of diagnosis and treatment. Int J Health Sci. 8:85\u2013104","journal-title":"Int J Health Sci."},{"issue":"S3","key":"582_CR3","first-page":"295","volume":"17","author":"A Assini","year":"2010","unstructured":"Assini A, Laricchia D, Pizzo R, Pandolfini L, Belletti M, Colucci M et al (2010) P1577: The carpal tunnel syndrome in diabetes: clinical and electrophysiological improvement after treatment with palmitoylethanolamide. Eur J Neurol. 17(S3):295","journal-title":"Eur J Neurol."},{"key":"582_CR4","doi-asserted-by":"publisher","first-page":"917350","DOI":"10.5402\/2011\/917350","volume":"2011","author":"C Bacci","year":"2011","unstructured":"Bacci C, Cassetta G, Emanuele B, Berengo M (2011) Randomized split-mouth study on postoperative effects of palmitoylethanolamide for impacted lower third molar surgery. ISRN surgery 2011:917350. https:\/\/doi.org\/10.5402\/2011\/917350","journal-title":"ISRN surgery"},{"key":"582_CR5","first-page":"1833","volume":"15","author":"N Bellamy","year":"1988","unstructured":"Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW (1988) Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 15:1833\u20131840","journal-title":"J Rheumatol."},{"key":"582_CR6","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2174\/1871527311312010008","volume":"12","author":"I Bettoni","year":"2013","unstructured":"Bettoni I, Comeli F, Colombo A, Bonfanti P, Costa B (2013) Non-neuronal cell modulation relieves neuropathic pain: efficacy of the endogenous lipid palmitoylethanolamide. CNS Neurol Disord Drug Targets 12:34\u201344","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"582_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ejpain.2006.02.013","volume":"11","author":"JM Bijordal","year":"2007","unstructured":"Bijordal JM, Klovnig A, Ljunggren AE, Slordal L (2007) Short-term efficacy of pharmacotherapeutic interventions in osteoarthritis knee pain: a meta-analysis of randomized placebo-controlled trials. Eur. J. Pain. 11:125\u2013138","journal-title":"Eur. J. Pain."},{"key":"582_CR8","doi-asserted-by":"publisher","first-page":"705","DOI":"10.2174\/1871527316666170321124949","volume":"16","author":"S Brotini","year":"2017","unstructured":"Brotini S, Schievano C, Guidi L (2017) Ultra-micronized palmitoylethanolamide: an efficacious adjuvant therapy for Parkinson\u2019s disease. CNS Neurol Disord Drug Targets 16:705\u2013713","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"582_CR9","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","volume":"2","author":"DJ Buysse","year":"1989","unstructured":"Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ (1989) The pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res. 2:193\u2013213","journal-title":"Psychiatry Res."},{"key":"582_CR10","doi-asserted-by":"publisher","first-page":"E23","DOI":"10.1111\/head.12136","volume":"57","author":"RS Calabro","year":"2017","unstructured":"Calabro RS, Bramanti P (2017) Occipital neuralgia responding to palmitoylethanolamide. Headache. 57:E23\u2013E24","journal-title":"Headache."},{"key":"582_CR11","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/28393","volume":"394","author":"A Calignano","year":"1998","unstructured":"Calignano A, La Rana G, Giuffrida A, Piomelli D (1998) Control of pain initiation by endogenous cannabinoids. Nature 394:277\u2013281","journal-title":"Nature"},{"key":"582_CR57","first-page":"227","volume":"25","author":"L Canteri","year":"2010","unstructured":"Canteri L, Petrosino S, Guida G (2010) Reduction in consumption of anti-inflammatory and analgesic medication in the treatment of chronic neuropathic pain in patients affected by compression lumbosciatic pain, due to treatment with Normast 300 mg. Dolor 25:227\u2013234","journal-title":"Dolor"},{"key":"582_CR12","doi-asserted-by":"publisher","first-page":"16044","DOI":"10.1038\/boneres.2016.44","volume":"5","author":"D Chen","year":"2017","unstructured":"Chen D, Shen J, Zhao W, Wang T, Han L, Hamilton J et al (2017) Osteoarthritis: toward a comprehensive understanding of pathological mechanism. Bone Res. 5:16044","journal-title":"Bone Res."},{"key":"582_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.pjnns.2017.11.002","volume":"52","author":"D Chirchiglia","year":"2018","unstructured":"Chirchiglia D, Chirchiglia P, Signorelli F (2018) Nonsurgical lumbar radiculopathies treated with ultramicronized palmitoylethanolamide (umPEA): a series of 100 cases. Neurol Neurochir Pol. 52:44\u201347","journal-title":"Neurol Neurochir Pol."},{"key":"582_CR14","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ejogrb.2011.04.011","volume":"158","author":"L Cobellis","year":"2011","unstructured":"Cobellis L, Castaldi MA, Giordano V, Trabucco E, De Franciscis P, Torella M et al (2011) Effectiveness of the association micronized N-Palmitoylethanolamine (PEA)-transpolydatin in the treatment of chronic pelvic pain related to endometriosis after laparoscopic assessment: a pilot study. Eur J Obstet Gynecol Reprod Biol. 158:82\u201386","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"key":"582_CR15","first-page":"141","volume":"102","author":"R Conigliaro","year":"2011","unstructured":"Conigliaro R, Drago V, Foster PS, Schievano C, Di Marzo V (2011) Use of palmitoylethanolamide in the entrapment neuropathy of the median in the wrist. Minerva Med. 102:141\u2013147","journal-title":"Minerva Med."},{"key":"582_CR16","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.pain.2008.06.003","volume":"139","author":"B Costa","year":"2008","unstructured":"Costa B, Comelli F, Bettoni I, Colleoni M,Giagnoni G (2008) The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB1, TRPV1 and PPAR\u03b3 receptors and neurotrophic factors. Pain. 139 541\u2013550.","journal-title":"Pain"},{"key":"582_CR17","first-page":"62","volume":"1","author":"P Desio","year":"2011","unstructured":"Desio P (2011) Combination of oxycodone and palmitoylethanolamide for low back pain treatment. AMC. 1:62\u201371","journal-title":"AMC."},{"key":"582_CR18","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2217\/pmt.12.5","volume":"2","author":"MC Dominguez","year":"2012","unstructured":"Dominguez MC, Martin AD, Ferrer FG, Puertas ML, Muro AL, Gonzalez JM et al (2012) N -palmitoylethanolamide in the treatment of the neuropathic pain associated with lumbosciatica. Pain Manag. 2:119\u2013124","journal-title":"Pain Manag."},{"key":"582_CR19","first-page":"237","volume":"13","author":"E Esposito","year":"2013","unstructured":"Esposito E, Cuzzocrea S (2013) Palmitoylethanolamide is a new possible pharmacological treatment for the inflammation associated with trauma. Mini Rev Med Chem. 13:237\u2013255","journal-title":"Mini Rev Med Chem."},{"key":"582_CR20","doi-asserted-by":"publisher","first-page":"291","DOI":"10.2174\/1871527317666180420143830","volume":"17","author":"M Evangelista","year":"2018","unstructured":"Evangelista M, Cilli V, De Vitis RE, Militerno A, Fanfani F (2018) Ultramicronized palmitoylethanolamide effects on sleep-wake rhythm and neuropathic pain phenotypes in patients with carpal tunnel syndrome: an open-label, randomized controlled study. CNS Neurol DIsord Drug Targets. 17:291\u2013298","journal-title":"CNS Neurol DIsord Drug Targets."},{"key":"582_CR21","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1111\/j.1526-4637.2012.01432.x","volume":"13","author":"A Gatti","year":"2012","unstructured":"Gatti A, Lazzari M, Gianfelice V, Di Paolo A, Sabato E, Sabato AF (2012) Palmitoylethanolamide in the treatment of chronic pain caused by different etiopathogenesis. Pain Med. 13:1121\u20131130","journal-title":"Pain Med."},{"key":"582_CR22","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jad.2018.02.057","volume":"232","author":"M Ghazizadeh-Hashem","year":"2018","unstructured":"Ghazizadeh-Hashem M, Ghajar A, Shalbafan MR, Ghazizadeh-Hashemi,F., Afarideh, M., Malekpour F., et al. (2018) Palmitoylethanolamide as adjunctive therapy in major depressive disorder: A double-blind, randomized and placebo-controlled trial. J. Affect. Disord. 232:127-133.","journal-title":"J Affect Disord"},{"key":"582_CR23","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ejogrb.2013.01.009","volume":"168","author":"E Giugliano","year":"2013","unstructured":"Giugliano E, Cagnazzo E, Soave I, Lo Monte G, Wenger JM, Marci R (2013) The adjuvant use of N-palmitoylethanolamine and transpolydatin in the treatment of endometriotic pain. Eur. J. Obstet. Gynecol Reprod Biol. 168:209\u2013213","journal-title":"Eur. J. Obstet. Gynecol Reprod Biol."},{"key":"582_CR24","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41598-017-00342-1","volume":"7","author":"F Guida","year":"2017","unstructured":"Guida F, Luongo L, Boccella S, Giordano ME, Romano R, Bellini G et al (2017) Palmitoylethanolamide induces microglia changes associated with increased migration and phagocytic activity: involvement of the CB2 receptor. Sci Rep. 7:375","journal-title":"Sci Rep"},{"key":"582_CR25","doi-asserted-by":"publisher","first-page":"S240","DOI":"10.1002\/acr.20543","volume":"63","author":"GA Hawker","year":"2011","unstructured":"Hawker GA, Mian S, Kendzerska T, Fench M (2011) Measures of adult pain: visual analog scale for pain (VAS Pain), numeric rating scale for pain (NRS pain), McGill pain questionnaire (MPQ), short-form McGill pain questionnaire (SF-MPQ), chronic pain grade scale (CPGS), short form-36 bodily pain scale (SF-36 BPS), and measure of intermittent and constant osteoarthritis pain (ICOAP). Arthritis Care Res. 63:S240\u2013S252 (UP1 11).","journal-title":"Arthritis Care Res"},{"key":"582_CR26","doi-asserted-by":"publisher","first-page":"729","DOI":"10.2147\/JPR.S93106","volume":"8","author":"K Hesselink","year":"2015","unstructured":"Hesselink K, Kopsky DJ (2015) Palmitoylethanolamide, a neutraceutical, in nerve compression syndromes: efficacy and safety in sciatic pain and carpal tunnel syndrome. J. Pain Res. 8:729\u2013734","journal-title":"J. Pain Res."},{"key":"582_CR27","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/bjp.2008.324","volume":"155","author":"W Ho","year":"2008","unstructured":"Ho W, Barrett D, Randall M (2008) \u2018Entourage\u2019 effects of N-palmitoylethanolamide andN-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors. Brit J Pharmacol. 155:837\u2013846","journal-title":"Brit J Pharmacol."},{"key":"582_CR28","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1002\/acr.20142","volume":"62","author":"JR Hochman","year":"2010","unstructured":"Hochman JR, French MF, Bermingham SL, Hawker GA (2010) The nerve of osteoarthritis pain. Arthritis Care Res. 62:1019\u20131023","journal-title":"Arthritis Care Res."},{"key":"582_CR29","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ejogrb.2010.01.008","volume":"150","author":"U Indraccolo","year":"2010","unstructured":"Indraccolo U, Barbieri F (2010) Effect of palmitoylethanolamide\u2010polydatin combination on chronic pelvic pain associated with endometriosis: preliminary observations. Eur J Obstet Gynecol Reprod Biol 150:76\u201379","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"582_CR30","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2147\/JPR.S32143","volume":"5","author":"JM Keppel Hesselink","year":"2012","unstructured":"Keppel Hesselink JM, Hekker TAM (2012) Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series. J Pain Res. 5:437\u2013442","journal-title":"J Pain Res."},{"key":"582_CR31","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1046\/j.1528-1157.2001.41499.x","volume":"42","author":"DM Lambert","year":"2001","unstructured":"Lambert DM, Vandevoorde S, Diependaele G, Govaerts SJ, Robert AR (2001) Anticonvulsant activity of N-palmitoylethanolamide, a putative endocannabinoid, in mice. Epilepsia. 42:321\u2013327","journal-title":"Epilepsia."},{"key":"582_CR32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3111\/13696998.2012.729548","volume":"16","author":"PC Langley","year":"2013","unstructured":"Langley PC, Van Litsenburg C, Cappelleri JC, Carroll D (2013) The burden associated with neuropathic pain in Western Europe. J Med Econ. 16:85\u201395","journal-title":"J Med Econ."},{"key":"582_CR33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0022-3999(93)90120-5","volume":"37","author":"S Levenstein","year":"1993","unstructured":"Levenstein S, Prantera C, Varvo V, Scribano ML, Berto E, Luzi C, Andreoli A (1993) Development of the perceived stress questionnaire: a new tool for psychosomatic research. J Psychosom Res. 37:19\u201332","journal-title":"J Psychosom Res."},{"key":"582_CR34","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1002\/art.34453","volume":"64","author":"R Loeser","year":"2012","unstructured":"Loeser R, Goldring S, Scanzello C, Goldring M (2012) osteoarthritis: a disease of the joint as an organ. Arthritis Rheum. 64:1697\u20131707","journal-title":"Arthritis Rheum."},{"key":"582_CR35","first-page":"37","volume":"7","author":"GS Man","year":"2014","unstructured":"Man GS, Mologhianu G (2014) Osteoarthritis pathogenesis - a complex process that involves the entire joint. J Med Life. 7:37\u201341","journal-title":"J Med Life."},{"key":"582_CR36","first-page":"99","volume":"26","author":"I Marini","year":"2012","unstructured":"Marini I, Bartolucci ML, Bortolotti F, Gatto MR, Bonetti GA (2012) Palmitoylethanolamide versus a nonsteroidal anti-inflammatory drug in the treatment of temporomandibular joint inflammatory pain. J Orofac Pain. 26:99\u2013104","journal-title":"J Orofac Pain."},{"key":"582_CR37","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0014-2999(96)00015-5","volume":"300","author":"S Mazzari","year":"1996","unstructured":"Mazzari S, Canella R, Petrelli L, Marcolongo G, Leon A (1996) N-(2 hydroxyethyl)-hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation. Eur J Pharmacol. 300:227\u2013236","journal-title":"Eur J Pharmacol."},{"key":"582_CR38","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.2147\/JPR.S154002","volume":"11","author":"J Mora","year":"2018","unstructured":"Mora J, Przkora R, Cruz-Almeida Y (2018) Knee osteoarthritis: pathophysiology and current treatment modalities. J Pain Res. 11:2189\u20132196","journal-title":"J Pain Res."},{"key":"582_CR39","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.joca.2013.03.018","volume":"21","author":"T Neogi","year":"2013","unstructured":"Neogi T (2013) The epidemiology and impact of pain in osteoarthritis. Osteoarthritis Cartilage 21:1145\u20131153","journal-title":"Osteoarthritis Cartilage"},{"key":"582_CR40","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/j.1601-5215.2007.00217.x","volume":"19","author":"F Ng","year":"2007","unstructured":"Ng F, Trauer T, Dodd S, Callaly T, Campbell S, Berk M (2007) The validity of the 21\u2013item version of the depression anxiety stress scales as a routine clinical outcome measure. Acta Neuropsychiatrica. 19:304\u2013310","journal-title":"Acta Neuropsychiatrica."},{"key":"582_CR41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.36076\/ppj\/2016.19.11","volume":"19","author":"A Paladini","year":"2016","unstructured":"Paladini A, Fusco M, Cenacchi T, Schlevano C, Piroll A, Varrassi G (2016) Palmitoylethanolamide, a special food for medical purposes, in the treatment of chronic pain: a pooled data meta-analysis. Pain Physician. 19:11\u201324","journal-title":"Pain Physician."},{"key":"582_CR42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.36076\/ppj\/2016.19.11","volume":"19","author":"A Paladini","year":"2016","unstructured":"Paladini A, Fusco M, Cenacchi T, Schievano C, Piroli A, Varrassi G (2016) Palmitoylethanolamide, a special food for medical purposes, in the treatment of chronic pain: a pooled data meta-analysis. Pain Physician. 19:11\u201324","journal-title":"Pain Physician."},{"key":"582_CR43","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.ijom.2010.06.003","volume":"39","author":"JW Park","year":"2010","unstructured":"Park JW, Clark GT, Kim YK, Chung JW (2010) Analysis of thermal pain sensitivity and psychological profiles in different subgroups of TMD patients. Int J Oral Maxillofac Surg. 39:968\u2013974","journal-title":"Int J Oral Maxillofac Surg."},{"key":"582_CR45","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1111\/bph.13580","volume":"174","author":"S Petrosino","year":"2017","unstructured":"Petrosino S, Di Marzo V (2017) The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations. Br J Pharmacol. 174:1349\u20131365","journal-title":"Br J Pharmacol."},{"key":"582_CR46","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1038\/bjp.2008.335","volume":"155","author":"DR Sagar","year":"2008","unstructured":"Sagar DR, Kendall DA, Chapman V (2008) Inhibition of fatty acid amide hydrolase produces PPAR-a-mediated analgesia in a rat model of inflammatory pain. Br J Pharmacol. 155:1297\u20131306","journal-title":"Br J Pharmacol."},{"key":"582_CR47","first-page":"849623","volume":"2014","author":"C Schifilliti","year":"2014","unstructured":"Schifilliti C, Cucinotta L, Fedele V, Ingegnosi C, Luca S, Leotta C (2014) Micronized palmitoylethanolamide reduces the symptoms of neuropathic pain in diabetic patients. Pain Res Treat. 2014:849623","journal-title":"Pain Res Treat."},{"key":"582_CR48","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10787-013-0191-7","volume":"22","author":"SD Skaper","year":"2014","unstructured":"Skaper SD, Facci L, Fusco M, della Valle MF, Zusso M, Costa B, et al (2014) Palmitoylethanolamide, a naturally-occurring disease modifying agent in neuropathic pain. Inflammopharmacology 22:79\u201394","journal-title":"Inflammopharmacology"},{"key":"582_CR49","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s12640-014-9465-0","volume":"2","author":"I Smaga","year":"2014","unstructured":"Smaga I, Bystrowska B, Gawli\u0144ski D, Pomierny B, Stankowicz P, Filip M (2014) Antidepressants and changes in concentration of endocannabinoids and N-Acylethanolamines in rat brain structures. Neurotox Res. 2:190\u2013206","journal-title":"Neurotox Res."},{"issue":"18","key":"582_CR50","first-page":"30197","volume":"S1526\u20135900","author":"N Stensson","year":"2018","unstructured":"Stensson N, Ghafouri N, Emberg M, Mannerkorpi K, Kosek E, Gerdie B et al (2018) The relationship of endocannabinoidome lipid mediators with pain and psychological stress in women with fibromyalgia: a case-control study. J. Pain. S1526\u20135900(18):30197\u201330204","journal-title":"J. Pain."},{"key":"582_CR51","doi-asserted-by":"publisher","first-page":"916","DOI":"10.2174\/187152711799219307","volume":"10","author":"A Truini","year":"2011","unstructured":"Truini A, Biasiotta A, Di Stefano G, La Cesa S, Leone C, Cartoni C et al (2011) Palmitoylethanolamide restores myelinated-fibre function in patients with chemotherapy-induced painful neuropathy. CNS Neurol Disord Drug Targets. 10:916\u2013920","journal-title":"CNS Neurol Disord Drug Targets."},{"key":"582_CR52","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware","year":"1992","unstructured":"Ware JE, Sherbourne CD (1992) The MOS 36-item short-form health status survey (SF-36). 1. Conceptual framework and item selection. Med Care. 30:473\u2013483","journal-title":"Med Care."},{"key":"582_CR53","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.neuropharm.2007.06.003","volume":"54","author":"LE Wise","year":"2008","unstructured":"Wise LE, Cannavacciulo R, Cravatt BF, Muran BF, Lichtman AH (2008) Evaluation of fatty acid amines in the carrageenan-induced paw odema model. Neuropharmacology 54:181\u2013188","journal-title":"Neuropharmacology"},{"key":"582_CR54","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/978-3-662-46450-2_7","volume":"227","author":"SG Woodhams","year":"2015","unstructured":"Woodhams SG, Sagar DR, Burston JJ, Chapman V (2015) The role of the endocannabinoid system in pain. Handb Exp Pharmacol. 227:119\u2013143","journal-title":"Handb Exp Pharmacol."},{"key":"582_CR55","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.joca.2007.12.013","volume":"16","author":"W Zhang","year":"2008","unstructured":"Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N et al (2008) OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 16:137\u2013162","journal-title":"Osteoarthritis Cartilage"},{"key":"582_CR56","doi-asserted-by":"publisher","first-page":"15040","DOI":"10.1038\/boneres.2015.40","volume":"4","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Ouyang H, Dass CR, Xu J (2016) Current research on pharmacologic and regenerative therapies for osteoarthritis. Bone Res 4:15040","journal-title":"Bone Res"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-019-00582-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10787-019-00582-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-019-00582-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T19:19:04Z","timestamp":1663183144000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10787-019-00582-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,29]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["582"],"URL":"https:\/\/doi.org\/10.1007\/s10787-019-00582-9","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,29]]},"assertion":[{"value":"30 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Luis Vitetta has received National Institute of Complementary Medicine and National Health and Medical Research Council of Australia competitive funding and Industry support for research into nutraceuticals and herbal medicines. This\u00a0research project was industry funded.\u00a0None of the authors have a commercial interest in the\u00a0investigative product. None of the authors have declared any conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}